FTC Faces Uphill Battle In AndroGel Pay-For-Delay Suit
This article was originally published in The Pink Sheet Daily
Executive Summary
While the Federal Trade Commission won a court order requiring AbbVie to turn over documents in its AndroGel patent settlement the judge dismissed a big chunk of the agency’s complaint.